MedKoo Cat#: 573648 | Name: ALE-0540
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ALE-0540 is a nerve growth factor receptor antagonist that inhibits the binding of NGF to tyrosine kinase (Trk) A and/or p75. ALE-0540 also inhibits signal transduction and biological responses mediated by TrkA receptors.

Chemical Structure

ALE-0540
CAS#234779-34-1

Theoretical Analysis

MedKoo Cat#: 573648

Name: ALE-0540

CAS#: 234779-34-1

Chemical Formula: C14H11N3O5

Exact Mass: 301.0699

Molecular Weight: 301.26

Elemental Analysis: C, 55.82; H, 3.68; N, 13.95; O, 26.55

Price and Availability

Size Price Availability Quantity
50mg USD 750.00 2 Weeks
100mg USD 1,250.00 2 Weeks
1g USD 4,450.00 2 Weeks
2g USD 6,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
ALE-0540, ALE0540, ALE 0540
IUPAC/Chemical Name
1H-Benz(de)isoquinoline-1,3(2H)-dione, 2-((2-hydroxyethyl)amino)-5-nitro-
InChi Key
SURCGQGDUADKBL-UHFFFAOYSA-N
InChi Code
1S/C14H11N3O5/c18-5-4-15-16-13(19)10-3-1-2-8-6-9(17(21)22)7-11(12(8)10)14(16)20/h1-3,6-7,15,18H,4-5H2
SMILES Code
c1cc2cc(cc3c2c(c1)C(=O)N(C3=O)NCCO)[N+](=O)[O-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 301.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Owolabi JB, Rizkalla G, Tehim A, Ross GM, Riopelle RJ, Kamboj R, Ossipov M, Bian D, Wegert S, Porreca F, Lee DK. Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther. 1999 Jun;289(3):1271-6. PMID: 10336516. 2: Eibl JK, Strasser BC, Ross GM. Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro. Eur J Pharmacol. 2013 May 15;708(1-3):30-7. doi: 10.1016/j.ejphar.2013.03.029. Epub 2013 Mar 22. PMID: 23528360. 3: Sheffield KS, Kennedy AE, Scott JA, Ross GM. Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy. Anal Biochem. 2016 Jan 15;493:21-6. doi: 10.1016/j.ab.2015.09.019. Epub 2015 Oct 3. PMID: 26435172. 4: Sheffield KS, Vohra R, Scott JA, Ross GM. Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors. Pharmacol Res. 2016 Jan;103:292-9. doi: 10.1016/j.phrs.2015.12.005. Epub 2015 Dec 7. PMID: 26675716. 5: Oei HB, Hooker RS, Cipher DJ, Reimold A. High rates of stopping or switching biological medications in veterans with rheumatoid arthritis. Clin Exp Rheumatol. 2009 Nov-Dec;27(6):926-34. PMID: 20149307.